Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Accumulated Expenses (2020 - 2024)

Historic Accumulated Expenses for IceCure Medical (ICCM) over the last 5 years, with Q4 2024 value amounting to $4.0 million.

  • IceCure Medical's Accumulated Expenses rose 2663.7% to $4.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.0 million, marking a year-over-year increase of 2663.7%. This contributed to the annual value of $4.0 million for FY2024, which is 2663.7% up from last year.
  • Latest data reveals that IceCure Medical reported Accumulated Expenses of $4.0 million as of Q4 2024, which was up 2663.7% from $3.1 million recorded in Q4 2023.
  • Over the past 5 years, IceCure Medical's Accumulated Expenses peaked at $4.0 million during Q4 2024, and registered a low of $1.6 million during Q4 2022.
  • For the 5-year period, IceCure Medical's Accumulated Expenses averaged around $2.9 million, with its median value being $2.9 million (2021).
  • In the last 5 years, IceCure Medical's Accumulated Expenses plummeted by 4579.76% in 2022 and then surged by 9911.39% in 2023.
  • Over the past 5 years, IceCure Medical's Accumulated Expenses (Quarter) stood at $2.9 million in 2020, then increased by 2.1% to $2.9 million in 2021, then crashed by 45.8% to $1.6 million in 2022, then surged by 99.11% to $3.1 million in 2023, then rose by 26.64% to $4.0 million in 2024.
  • Its Accumulated Expenses stands at $4.0 million for Q4 2024, versus $3.1 million for Q4 2023 and $1.6 million for Q4 2022.